Todd C. Somers
15Patents
8h-index
23Co-inventors
68Inventor score
Filing activity: Jul 18, 1991 → Aug 19, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5532359A | Ras farnesyl transferase inhibitors | Human Necessities | 98 | Expired |
| US5250732A | Ketamine analogues for treatment of thrombocytopenia | Chemistry; Metallurgy | 45 | Expired |
| US5843941A | Ras farnesyl transferase inhibitors | Human Necessities | 32 | Expired |
| US5565449A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor | Chemistry; Metallurgy | 27 | Expired |
| US5798337A | Low molecular weight peptidomimetic growth hormone secretagogues | Human Necessities | 27 | Expired |
| US5384331A | Ketamine analogues for treatment of thrombocytopenia | Chemistry; Metallurgy | 25 | Expired |
| US5674863A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor | Chemistry; Metallurgy | 10 | Expired |
| US5663166A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor | Chemistry; Metallurgy | 9 | Expired |
| US5674865A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a | Chemistry; Metallurgy | 8 | Expired |
| US6171578A | Benzodiazepine derivatives for imaging thrombi | Human Necessities | 8 | Expired |
| US5716951A | Tricyclic inhibitors of the vitronectin receptor | Human Necessities | 3 | Expired |
| US5705890A | Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor | Human Necessities | 3 | Expired |
| US6034216A | Low molecular weight peptidomimetic growth hormone secretagogues | Human Necessities | 3 | Expired |
| US5493020A | Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor | Human Necessities | 2 | Expired |
| US7094869B2 | Low molecular weight peptidomimetic growth hormone secretagogues | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.